Dmitry Borisov
Executive Director
UICC, 28 August, 2012
- RUSSIA. WHEN THE RIGHT TO LIFE
RUSSIA. WHEN THE RIGHT TO LIFE IS DENIED Dmitry Borisov Executive - - PowerPoint PPT Presentation
RUSSIA. WHEN THE RIGHT TO LIFE IS DENIED Dmitry Borisov Executive Director UICC, 28 August, 2012 Oncology in figures 2.8 million of registered patients, i.e. 1.8 % of population 516 thousand new cases of malignant tumors (this indicator
Dmitry Borisov
Executive Director
UICC, 28 August, 2012
exceeded half a million of new patients annually
Source: National Cancer Institute SEER database; “Oncology statistic in Russia”, Chissov V.I., 2010!
BUT in fact low availability of diagnostics and innovative treatment
events)
EQUAL RIGHT TO LIFE Treatment Denials DATABASE Complaints/Appeals Questionnaires Hotline / Web PTS Schools Sociologic Studies
Direct Appeals from Patients
Ministry of Health ROSZDRAVNADZOR (Russian FDA)
Over 1500 cases were submitted to HA Over 7’000 PTS questionnaires and complaint letters have been received Local HA State Hospitals Equal Right to Life is the member of PTS’ Rights Counsil
Over 500 PTS Access to Treatment Provided
“WHITE BOOK” - annually issued edition providing information on all cases of refusal in cancer treatment managed by Equal Right to Life Provided to all regional and federal decision-making authorities in the sphere of healthcare
Source: Pharmexpert (antineoplastic market), RML, *forecast
per capita!
per capita!
per capita!
per capita!
per capita!
per capita!
!
Serbia (7 mln) = 15 USD! Kosovo (2 mln) = 19 USD!
Structure of funds, bln RUR Cancer epidemiology Total 2.8 mln
4.3%
= "26.7%
Out+of+pocket hospital reimbursement
Source: Pharmexpert, 2011
! Implement treatment guidelines that have to be based on therapeutic and financial efficacy! ! Introduce 100% capping State financing programs & options for co-payments (private insurance etc.)! ! Improve quality of statistical & epidemiology data that is essential for budget and financial management! ! Introduce patients’ rights oriented legislation on generics and biosimilars ! ! Increase awareness & patients' education!
GTF.CCC Report - Closing the Cancer Divide!
UN & WHO!
implementation!
and policy making ! PAGs & Medical Associations!